3D腹腔镜与传统腹腔镜在肾部分切除术中的临床效果比较  

Comparison of clinical effect between 3D laparoscopy and traditional laparoscopy in partial nephrectomy

作　　者：刘海涛[1] 关超[1] 

机构地区：[1]蚌埠医学院第二附属医院泌尿外科,安徽蚌埠233040

出　　处：《蚌埠医学院学报》2016年第12期1586-1588,共3页Journal of Bengbu Medical College

摘　　要：目的：比较3D腹腔镜和传统腹腔镜下行肾部分切除术的临床疗效,评价二者在肾部分切除术中的实用性、安全性及疗效。方法：选择拟行手术治疗的局限性肾脏肿瘤患者42例,其中采用3D腹腔镜下肾部分切除术22例（3D组）和传统腹腔镜下肾部分切除术20例（传统组）。所有手术均由同一手术团队完成。比较2组手术时间、热缺血时间、术中出血量、手术费用和并发症发生情况。结果：3D组手术时间明显少于传统组（P〈0.01）,热缺血时间亦少于传统组（P〈0.05）;2组手术费用和术中出血量差异均无统计学意义（P〉0.05）;2组均有1例切口延迟愈合,保守治疗后均治愈;2组手术切缘均阴性。随访6~48个月,2组均未见复发和转移,肾功能正常。结论：与传统腹腔镜手术相比,3D腹腔镜三维视野高清,解剖层次清晰,有助于缩短手术时间和肾热缺血时间,值得临床推广应用。Objective： To compare the clinical effects of 3D laparoscopy with traditional laparoscopy in partial nephrectomy,and evaluate their practicability and safety. Methods： Among 42 limited renal tumor patients scheduled by operation,which were treated with partial nephrectomy under 3D laparoscopy（ 3D group,22 cases） and traditional laparoscopy（ traditional group,20 cases）,respectively.All operations were completed by the same operators. The operation time,warm ischemia time,peroperative bleeding,operation cost and complications between two groups were compared. Results： The operation time and warm ischemia time in 3D group were significantly less than those in traditional group（ P〈0. 01 and P〈0. 05）. The differences of the operation cost and peroperative bleeding between two groups were not statistical significance（ P〉0. 05）. One incision with delayed healing in 3D group and traditional group were found,which cured after conservative treatment. The surgical margins in two groups were negative. All cases were followed up for 6 to 48 months,no recurrence and metastasis,and normal kidney function were identified in two groups. Conclusions： Compared with the traditional laparoscopy surgery,the vision and anatomic structure under 3D laparoscopy are clear. The 3D laparoscopy can help to shorten the operation and warm ischemia time,which is worthy of clinic application.

关 键 词：肾肿瘤 保留肾单位手术 3D腹腔镜 微创重建手术 

分 类 号：R737.11[医药卫生—肿瘤]